Endotoxemia clinical trials at UCSF

1 research study open to eligible people

Endotoxemia occurs when bacterial toxins enter the blood. UCSF is testing the PMX filter to see if it can improve treatment for septic shock caused by endotoxemia. This study compares the usual treatment with treatment that includes the PMX filter.

Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
open to eligible people ages 18 years and up
Prospective, multicenter, randomized, open-label study of standard of care plus the PMX cartridge versus standard of care alone in patients with endotoxemic septic shock
San Francisco, California and other locations

Last updated: June 2023

Endotoxemia clinical trials at UCSF

Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study